At a glance

The Galapagos group CSR report
Galapagos NV • Annual Report 2018

(XLS:) Download XLS

Consolidated Key Figures

(thousands of €, if not stated otherwise)

Year ended 31 December 2018

Year ended 31 December 2017

Year ended 31 December 2016

(1)

Our revenues, shareholders’ equity and deferred income for the year ended 31 December 2018 were influenced by the adoption of the new standard IFRS 15 – Revenue from contracts with customers, on 1 January 2018. We refer to the notes of this consolidated financial report for additional information.

(2)

The operational cash burn (or operational cash flow if this performance measure is positive) is equal to the sum of the net cash flows generated / used (-) in operating activities and the net cash flows generated / used (-) in investing activities minus (i) the proceeds or cash used, if any, in acquisitions or disposals of businesses; and (ii) the movement in restricted cash, if any. This alternative performance measure is in our view an important metric for a biotech company in the development stage.

INCOME STATEMENT

 

 

 

Revenues(1)

288,836

127,087

129,519

Other income

29,009

28,830

22,093

R&D expenditure

(322,875)

(218,502)

(139,573)

S, G&A expenses

(39,776)

(27,218)

(23,530)

Operating expenses

(362,652)

(245,720)

(163,103)

Operating loss

(44,807)

(89,802)

(11,491)

Net financial results

15,598

(25,705)

65,737

Taxes

(50)

(198)

(235)

Net income / loss (-)

(29,259)

(115,704)

54,012

 

 

 

 

BALANCE SHEET

 

 

 

Cash and cash equivalents

1,290,796

1,151,211

973,241

R&D incentives receivables

84,646

75,783

64,342

Assets

1,439,496

1,286,274

1,083,338

Shareholders’ equity(1)

1,214,249

1,011,983

758,701

Deferred income(1)

149,801

219,892

285,612

Other liabilities

75,446

54,399

39,025

 

 

 

 

CASH FLOW

 

 

 

Operational cash burn (-) / operational cash flow(2)

(158,379)

(154,089)

231,881

Cash flow from financing activities

287,876

353,357

395,996

Increase in cash and cash equivalents

129,497

205,778

628,111

Effect of currency exchange rate fluctuation on cash and cash equivalents

10,089

(27,808)

4,816

Cash and cash equivalents on 31 December

1,290,796

1,151,211

973,241

 

 

 

 

FINANCIAL RATIOS

 

 

 

Number of shares issued on 31 December

54,465,421

50,936,778

46,256,078

Basic income / loss (-) per share (in €)

(0.56)

(2.34)

1.18

Diluted income / loss (-) per share (in €)

(0.56)

(2.34)

1.14

Share price on 31 December (in €)

80.56

78.98

60.94

Total group employees on 31 December (number)

725

600

508
Employees per site

Employees per site (graphic)

Number of employees Galapagos group

Number of R&D employees (bar chart)